Extracellular vesicles in lung microenvironment and pathogenesis

Trends in Molecular Medicine

Volumn 21, Issue 9, 2015, Pages 533-542

  Fujita, Yu ^a,b,c   Kosaka, Nobuyoshi ^a,d   Araya, Jun ^b   Kuwano, Kazuyoshi ^b   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

COPD; Exosome; Extracellular vesicle; Lung cancer; Mesenchymal stem cell; MicroRNA

Indexed keywords

MICRORNA; PROTEIN;

AIRWAY; BIOGENESIS; CANCER CELL; CELL COMMUNICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXOSOME; HUMAN; LUNG CANCER; LUNG DISEASE; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NONHUMAN; PATHOGENESIS; REVIEW; TUMOR GROWTH; ANIMAL; GENETICS; METABOLISM; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; CELLULAR MICROENVIRONMENT; EXTRACELLULAR VESICLES; HUMANS; LUNG DISEASES; PROTEINS;

EID: 84940580351     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2015.07.004     Document Type: Review

References (98)

1. Shaykhiev R., et al. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell. Mol. Life Sci. 2011, 68:877-892.
2. Evans M.J., et al. The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. Am. J. Respir. Cell Mol. Biol. 1999, 21:655-657.
3. Araya J., et al. Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit. Am. J. Pathol. 2006, 169:405-415.
4. Shannon J.M., et al. Mesenchyme specifies epithelial differentiation in reciprocal recombinants of embryonic lung and trachea. Dev. Dyn. 1998, 212:482-494.
5. Demayo F., et al. Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process?. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L510-L517.
6. Maniatis N.A., Orfanos S.E. The endothelium in acute lung injury/acute respiratory distress syndrome. Curr. Opin. Crit. Care 2008, 14:22-30.
7. Holgate S.T. Epithelial damage and response. Clin. Exp. Allergy 2000, 30(Suppl. 1):37-41.
8. Araya J., et al. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J. Clin. Invest. 2007, 117:3551-3562.
9. Raposo G., Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200:373-383.
10. Kulshreshtha A., et al. Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation. J. Allergy Clin. Immunol. 2013, 131:1194-1203.
11. Fujita Y., et al. Intercellular communication by extracellular vesicles and their microRNAs in asthma. Clin. Ther. 2014, 36:873-881.
12. Admyre C., et al. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur. Respir. J. 2003, 22:578-583.
13. Kosaka N., et al. Functional analysis of exosomal microRNA in cell-cell communication research. Methods Mol. Biol. 2013, 1024:1-10.
14. Pan B.T., Johnstone R.M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 1983, 33:967-978.
15. Simpson R.J., et al. Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8:4083-4099.
16. El Andaloussi S., et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 2013, 12:347-357.
17. Escola J.M., et al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 1998, 273:20121-20127.
18. Yoshioka Y., et al. Comparative marker analysis of extracellular vesicles in different human cancer types. J. Extracell. Vesicles 2013, 2:20424.
19. Castellana D., et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res. 2009, 69:785-793.
20. Beyer C., Pisetsky D.S. The role of microparticles in the pathogenesis of rheumatic diseases. Nat. Rev. Rheumatol. 2010, 6:21-29.
21. Witwer K.W., et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles 2013, 2:20360.
22. Gould S.J., Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles 2013, 2:20389.
23. Valadi H., et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
24. Porro C., et al. Isolation and characterization of microparticles in sputum from cystic fibrosis patients. Respir. Res. 2010, 11:94.
25. Bastarache J.A., et al. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L1035-L1041.
26. Kesimer M., Gupta R. Physical characterization and profiling of airway epithelial derived exosomes using light scattering. Methods 2015, Published online March 27, 2015. 10.1016/j.ymeth.2015.03.013.
27. Rose M.C., Voynow J.A. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 2006, 86:245-278.
28. Kesimer M., et al. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 2009, 23:1858-1868.
29. Ismail N., et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 2013, 121:984-995.
30. Bourdonnay E., et al. Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling. J. Exp. Med. 2015, 212:729-742.
31. Eltom S., et al. Respiratory infections cause the release of extracellular vesicles: implications in exacerbation of asthma/COPD. PLoS ONE 2014, 9:e101087.
32. Beninson L.A., Fleshner M. Exosomes: an emerging factor in stress-induced immunomodulation. Seminars in immunology 2014, 26:394-401.
33. Baixauli F., et al. Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front. Immunol. 2014, 5:403.
34. Anand P.K., et al. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria. PLoS ONE 2010, 5:e10136.
35. 2+ mobilization. Inflamm. Res. 2014, 63:539-547.
36. Yu J., et al. Integrating miRNA and mRNA expression profiles in response to heat stress-induced injury in rat small intestine. Funct. Integr. Genomics 2011, 11:203-213.
37. Sharma S., et al. Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy. EMBO Mol. Med. 2012, 4:617-632.
38. Beninson L.A., et al. Acute stressor exposure modifies plasma exosome-associated heat shock protein 72 (Hsp72) and microRNA (miR-142-5p and miR-203). PLoS ONE 2014, 9:e108748.
39. Montecalvo A., et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012, 119:756-766.
40. Gordon C., et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am. J. Respir. Crit. Care Med. 2011, 184:224-232.
41. Letsiou E., et al. Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding. Am. J. Respir. Cell Mol. Biol. 2015, 52:193-204.
42. Liu H., et al. Circulating endothelial microparticles involved in lung function decline in a rat exposed in cigarette smoke maybe from apoptotic pulmonary capillary endothelial cells. J. Thorac. Dis. 2014, 6:649-655.
43. Li M., et al. Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1818-1824.
44. Li C.J., et al. Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke. Am. J. Pathol. 2013, 182:1552-1562.
45. Moon H.G., et al. CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 307:L326-L337.
46. Novelli F., et al. Procoagulant, tissue factor-bearing microparticles in bronchoalveolar lavage of interstitial lung disease patients: an observational study. PLoS ONE 2014, 9:e95013.
47. Kosaka N., et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285:17442-17452.
48. Ostrowski M., et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010, 12:19-30.
49. Hsu C., et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 2010, 189:223-232.
50. Raiborg C., Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009, 458:445-452.
51. Savina A., et al. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J. Biol. Chem. 2003, 278:20083-20090.
52. Yu X., et al. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006, 66:4795-4801.
53. Yu X., et al. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 2009, 276:2201-2212.
54. Hao S., Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 2009, 10:281-288.
55. Qazi K.R., et al. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax 2010, 65:1016-1024.
56. Hogg J.C., Timens W. The pathology of chronic obstructive pulmonary disease. Annu. Rev. Pathol. 2009, 4:435-459.
57. Lambrecht B.N., Hammad H. The airway epithelium in asthma. Nat. Med. 2012, 18:684-692.
58. Hogg J.C., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl. J. Med. 2004, 350:2645-2653.
59. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
60. de Boer W.I., et al. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998, 158:1951-1957.
61. Takizawa H., et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 2001, 163:1476-1483.
62. Fujii S., et al. Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease. Oncoimmunology 2012, 1:630-641.
63. Schutze N., et al. 5' flanking sequence of the human immediate early responsive gene ccn1 (cyr61) and mapping of polymorphic CA repeat sequence motifs in the human ccn1 (cyr61) locus. Mol. Pathol. 2001, 54:170-175.
64. Moon H.G., et al. CCN1 secretion induced by cigarette smoking extracts augments IL-8 release from bronchial epithelial cells. PLoS ONE 2013, 8:e68199.
65. Lockett A.D., et al. Active trafficking of alpha 1 antitrypsin across the lung endothelium. PLoS ONE 2014, 9:e93979.
66. Takahashi T., Kubo H. The role of microparticles in chronic obstructive pulmonary disease. Int. J. Chronic Obstructive Pulmonary Dis. 2014, 9:303-314.
67. Pao W., Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol. 2011, 12:175-180.
68. Fujita Y., et al. The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research. BioMed Res. Int. 2014, 2014:486413.
69. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
70. Fujita Y., et al. RNAi therapeutic platforms for lung diseases. Pharmaceuticals 2013, 6:223-250.
71. Fujita Y., et al. Development of small RNA delivery systems for lung cancer therapy. Int. J. Mol. Sci. 2015, 16:5254-5270.
72. Rabinowits G., et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 2009, 10:42-46.
73. Cazzoli R., et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J. Thorac. Oncol. 2013, 8:1156-1162.
74. Cui H., et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene 2015, 34:3640-3650.
75. Rana S., et al. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013, 15:281-295.
76. Fabbri M., et al. microRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2110-E2116.
77. Fontana S., et al. Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives. Proteomics 2013, 13:1581-1594.
78. Park J.O., et al. Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics 2013, 13:2125-2134.
79. Li Y., et al. Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis 2011, 32:1976-1983.
80. Yamashita T., et al. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Die Pharmazie 2013, 68:969-973.
81. Huang S.H., et al. Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells. Cancer Invest. 2013, 31:330-335.
82. Ueda K., et al. Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes. Sci. Rep. 2014, 4:6232.
83. Jakobsen K.R., et al. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J. Extracell. Vesicles 2015, 4:26659.
84. Choi D.Y., et al. Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment. Proteomics 2014, 14:1845-1856.
85. Jung J.H., et al. Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells. Proteomics 2015, 15:824-835.
86. Xiao X., et al. Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin. PLoS ONE 2014, 9:e89534.
87. Kosaka N., et al. Exosomal tumor-suppressive microRNAs as novel cancer therapy: 'exocure' is another choice for cancer treatment. Adv. Drug Deliv. Rev. 2013, 65:376-382.
88. Kosaka N., et al. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J. Biol. Chem. 2013, 288:10849-10859.
89. Li W., et al. Rab27A regulates exosome secretion from lung adenocarcinoma cells A549: involvement of EPI64. Acta Pathol. Microbiol. Immunol. Scand. 2014, 122:1080-1087.
90. Li J., et al. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome. Lung Cancer 2014, 86:144-150.
91. Marleau A.M., et al. Exosome removal as a therapeutic adjuvant in cancer. J. Transl. Med. 2012, 10:134.
92. Pittenger M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
93. Griffin M.D., et al. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?. Immunol. Cell Biol. 2013, 91:40-51.
94. Matthay M.A. Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome. Ann. Am. Thorac. Soc. 2015, 12(Suppl. 1):S54-S57.
95. Rani S., et al. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol. Ther. 2015, 23:812-823.
96. Lee J.W., et al. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 2011, 29:913-919.
97. Zhu Y.G., et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 2014, 32:116-125.
98. Lee C., et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012, 126:2601-2611.